TrialCancer2015

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Joseph M Herman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.